MiR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met

Journal of Neurochemistry

Volumn 135, Issue 2, 2015, Pages 274-286

  Lan, Fengming ^a   Yu, Huiming ^b   Hu, Man ^c   Xia, Tingyi ^d   Yue, Xiao ^e  

^a TIANJIN HOSPITAL   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^c SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^d AIR FORCE GENERAL HOSPITAL   (China)

^e TIANJIN HUANHU HOSPITAL   (China)

Author keywords

c Met; glioblastoma; irradiation; miR 144 3p; temozolomide

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MICRORNA 144 3P; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; SCATTER FACTOR RECEPTOR; STAT3 PROTEIN; TEMOZOLOMIDE; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; DACARBAZINE; MIRN144 MICRORNA, MOUSE; RADIOSENSITIZING AGENT;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER INHIBITION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIZATION; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RADIOSENSITIVITY; RADIOSENSITIZATION; SURVIVAL PREDICTION; SURVIVAL RATE; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; BRAIN NEOPLASMS; CELL SURVIVAL; DRUG EFFECTS; GENETICS; NUDE MOUSE; SURVIVAL; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DACARBAZINE; GLIOBLASTOMA; HUMANS; MICE; MICE, NUDE; MICRORNAS; PROTO-ONCOGENE PROTEINS C-MET; PTEN PHOSPHOHYDROLASE; RADIATION-SENSITIZING AGENTS; SURVIVAL ANALYSIS;

EID: 84943587619     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13272     Document Type: Article

References (45)

1. Akiyoshi S., Fukagawa T., Ueo H., et al,. (2012) Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases. Br. J. Cancer 107, 1345-1353.
2. Alam R., Schultz C. R., Golembieski W. A., Poisson L. M., and, Rempel S. A., (2013) PTEN suppresses SPARC-induced pMAPKAPK2 and inhibits SPARC-induced Ser78 HSP27 phosphorylation in glioma. Neuro. Oncol. 15, 451-461.
3. Ameres S. L., and, Zamore P. D., (2013) Diversifying microRNA sequence and function. Nat. Rev. Mol. Cell Biol. 14, 475-488.
4. Ben-Hamo R., and, Efroni S., (2013) MicroRNA-gene association as a prognostic biomarker in cancer exposes disease mechanisms. PLoS Comput. Biol. 9, e1003351.
5. Berthois Y., Delfino C., Metellus P., Fina F., Nanni-Metellus I., Al Aswy H., Pirisi V., Ouafik L., and, Boudouresque F., (2014) Differential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas: evidence that miR200a-3p is regulated by O(6)-methylguanine methyltransferase and promotes temozolomide responsiveness. Cancer Biol. Ther. 15, 938-950.
6. Boccaccio C., Ando M., Tamagnone L., Bardelli A., Michieli P., Battistini C., and, Comoglio P. M., (1998) Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 391, 285-288.
7. Boccaccio C., Luraghi P., and, Comoglio P. M., (2014) MET-mediated resistance to EGFR inhibitors: an old liaison rooted in colorectal cancer stem cells. Cancer Res. 74, 3647-3651.
8. Cao T., Li H., Hu Y., Ma D., and, Cai X., (2014) miR-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting E2F3. Tumour Biol. 35, 10759-10764.
9. Chen M., Nowak D. G., and, Trotman L. C., (2014) Molecular pathways: PI3K pathway phosphatases as biomarkers for cancer prognosis and therapy. Clin. Cancer Res. 20, 3057-3063.
10. Cheng R. B., Ma R. J., Wang Z. K., Yang S. J., Lin X. Z., Rong H., and, Ma Y., (2011) PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells. Mol. Cell. Biochem. 349, 149-157.
11. Cheng C., Li W., Zhang Z., Yoshimura S., Hao Q., Zhang C., and, Wang Z., (2013) MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10). J. Biol. Chem. 288, 13748-13761.
12. Dong G., Chen Z., Li Z. Y., Yeh N. T., Bancroft C. C., and, Van Waes C., (2001) Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Cancer Res. 61, 5911-5918.
13. Esteller M., (2011) Non-coding RNAs in human disease. Nat. Rev. Genet. 12, 861-874.
14. Fang L., Li H., Wang L., Hu J., Jin T., Wang J., and, Yang B. B., (2014) MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression. Oncotarget 5, 2974-2987.
15. Fernandez S., Genis L., and, Torres-Aleman I., (2014) A phosphatase-independent gain-of-function mutation in PTEN triggers aberrant cell growth in astrocytes through an autocrine IGF-1 loop. Oncogene 33, 4114-4122.
16. Gao Y., Zeng F., Wu J. Y., et al,. (2015) MiR-335 inhibits migration of breast cancer cells through targeting oncoprotein c-Met. Tumour Biol. 36, 2875-2883.
17. Garouniatis A., Zizi-Sermpetzoglou A., Rizos S., Kostakis A., Nikiteas N., and, Papavassiliou A. G., (2013) Vascular endothelial growth factor receptors 1,3 and caveolin-1 are implicated in colorectal cancer aggressiveness and prognosis-correlations with epidermal growth factor receptor, CD44v6, focal adhesion kinase, and c-Met. Tumour Biol. 34, 2109-2117.
18. Gavine P. R., Ren Y., Han L., et al,. (2015) Volitinib, a potent and highly selective c-Met inhibitor, effectively blocks c-Met signaling and growth in c-MET amplified gastric cancer patient-derived tumor xenograft models. Mol. Oncol. 9, 323-333.
19. Ghiso E., and, Giordano S., (2013) Targeting MET: why, where and how? Curr. Opin. Pharmacol. 13, 511-518.
20. de Giorgio A., Krell J., Harding V., Stebbing J., and, Castellano L., (2013) Emerging roles of competing endogenous RNAs in cancer: insights from the regulation of PTEN. Mol. Cell. Biol. 33, 3976-3982.
21. Graveel C. R., Tolbert D., and, Vande Woude G. F., (2013) MET: a critical player in tumorigenesis and therapeutic target. Cold Spring Harb. Perspect. Biol. 5, pii: a009209. doi: 10.1101/cshperspect.a009209.
22. Guo Y., Ying L., Tian Y., Yang P., Zhu Y., Wang Z., Qiu F., and, Lin J., (2013) miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling. FEBS J. 280, 4531-4538.
23. Iwaya T., Yokobori T., Nishida N., et al,. (2012) Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway. Carcinogenesis 33, 2391-2397.
24. Jin G., Kim M. J., Jeon H. S., et al,. (2010) PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers. Lung Cancer 69, 279-283.
25. Ju P., Liu Z., Jiang Y., et al,. (2015) Determination of a novel anticancer c-Met inhibitor LS-177 in rat plasma and tissues with a validated UPLC-MS/MS method: application to pharmacokinetics and tissue distribution study. Biomed. Chromatogr. 29, 1103-1111.
26. Kim I. G., Lee J. H., Kim S. Y., Kim J. Y., and, Cho E. W., (2014a) Fibulin-3 negatively regulates ALDH1 via c-MET suppression and increases gamma-radiation-induced sensitivity in some pancreatic cancer cell lines. Biochem. Biophys. Res. Commun. 454, 369-375.
27. Kim J., Kang H. S., Lee Y. J., Lee H. J., Yun J., Shin J. H., Lee C. W., Kwon B. M., and, Hong S. H., (2014b) EGR1-dependent PTEN upregulation by 2-benzoyloxycinnamaldehyde attenuates cell invasion and EMT in colon cancer. Cancer Lett. 349, 35-44.
28. Lan F., Pan Q., Yu H., and, Yue X., (2015) Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/beta-catenin signaling in glioblastoma. J. Neurochem. 134, 811-818.
29. Lee Y. Y., Kim H. P., Kang M. J., Cho B. K., Han S. W., Kim T. Y., and, Yi E. C., (2013) Phosphoproteomic analysis identifies activated MET-axis PI3K/AKT and MAPK/ERK in lapatinib-resistant cancer cell line. Exp. Mol. Med. 45, e64.
30. Liu S. Q., Jiang S., Li C., Zhang B., and, Li Q. J., (2014) miR-17-92 cluster targets phosphatase and tensin homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation. J. Biol. Chem. 289, 12446-12456.
31. Manterola L., Guruceaga E., Gallego Perez-Larraya J., et al,. (2014) A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool. Neuro. Oncol. 16, 520-527.
32. Mitamura T., Watari H., Wang L., et al,. (2013) Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET. Oncogenesis 2, e40.
33. Omuro A., and, DeAngelis L. M., (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310, 1842-1850.
34. Sanchez I., and, Dynlacht B. D., (2014) Cell biology: short RNAs and shortness of breath. Nature 510, 40-42.
35. Schwab R., Petak I., Kollar M., et al,. (2014) Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement. Lung Cancer 83, 109-111.
36. Schwartz S., Wongvipat J., Trigwell C. B., et al,. (2015) Feedback suppression of PI3Kalpha signaling in PTEN-Mutated tumors is relieved by selective inhibition of PI3Kbeta. Cancer Cell 27, 109-122.
37. Seok J. K., Lee S. H., Kim M. J., and, Lee Y. M., (2014) MicroRNA-382 induced by HIF-1alpha is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog. Nucleic Acids Res. 42, 8062-8072.
38. Sun S., Liu S., Duan S. Z., et al,. (2014) Targeting the c-Met/FZD8 signaling axis eliminates patient-derived cancer stem-like cells in head and neck squamous carcinomas. Cancer Res. 74, 7546-7559.
39. Wang S., Tie J., Wang R., et al,. (2015) SOX2, a predictor of survival in gastric cancer, inhibits cell proliferation and metastasis by regulating PTEN. Cancer Lett. 358, 210-219.
40. Weller M., Pfister S. M., Wick W., Hegi M. E., Reifenberger G., and, Stupp R., (2013) Molecular neuro-oncology in clinical practice: a new horizon. Lancet Oncol. 14, e370-e379.
41. Xie Y., Lu W., Liu S., et al,. (2014) Crosstalk between nuclear MET and SOX9/beta-catenin correlates with castration-resistant prostate cancer. Mol. Endocrinol. 28, 1629-1639.
42. Yamaue H., Tanimura H., Iwahashi M., Tani M., Tsunoda T., Tabuse K., Kuribayashi K., and, Saito K., (1989) Role of interleukin-2 and interferon-gamma in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432. Cancer Immunol. Immunother. 29, 79-86.
43. Yang C. H., Yue J., Pfeffer S. R., et al,. (2014) MicroRNA-21 promotes glioblastoma tumorigenesis by down-regulating insulin-like growth factor-binding protein-3 (IGFBP3). J. Biol. Chem. 289, 25079-25087.
44. Zhang L. Y., Ho-Fun Lee V., Wong A. M., et al,. (2013) MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Carcinogenesis 34, 454-463.
45. Zhao M., Huang J., Gui K., et al,. (2014) The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression. Int. J. Mol. Med. 34, 1565-1572.